ANTHONY ESTRADA,CHARLES BAKER-GLENN,DANIEL JON BURDICK,MARK CHAMBERS,HUIFEN CHEN,ZACHARY KEVIN SWEENEY,BRYAN K. CHAN
申请号：
PT11782588
公开号：
PT2638031T
申请日:
2011.11.09
申请国别(地区):
PT
年份:
2018
代理人:
摘要：
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein X, R 1 , R 2 , R 3 , R 4 and R 5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
